|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Predictive value of ^(18)F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma显示文摘Myeong Jun Song,Si Hyun Bae,Chung-Hwa Park,Jeong Won Jang,Jong Young Choi,Seung Kew Yoon,Department of Internal Medicine,College of Medicine,The Catholic University of Korea,Seoul 137-040,South Korea Ie Ryung Yoo,Department of Nuclear,Medicine College of Medicine,The Catholic University of Korea,Seoul 137-040,South Korea Ho Jong Chun,Byung Gil Choi,Hae Giu Lee,Department of Radiology,College of Medicine,The Catholic University of Korea,Seoul 137-040,South | Myeong Jun Song Si Hyun Bae Ie Ryung Yoo Chung-Hwa Park Jeong Won Jang Ho Jong Chun Byung Gil Choi Hae Giu Lee Jong Young Choi Seung Kew Yoon | 2012 | World Journal of Gastroenterology2012，18，25： | 8 |
| 2 | Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis显示文摘AIM: To evaluate the prognostic factors and efficacy of hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. METHODS: Fifty hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) were treated using hepatic arterial infusion chemotherapy (HAIC) via a subcutaneously implanted port. The epirubicin-cisplatin-5-fluorouracil (ECF) chemotherapeutic regimen consisted of 35 mg/m 2 epirubicin on day 1, 60 mg/m 2 cisplatin for 2 h on day 2, and 500 mg/m 2 5-fluorouracil for 5 h on days 1-3. The treatments were repeated every 3 or 4 wk. RESULTS: Three (6%) of the 50 patients achieved a complete response (CR), 13 (26%) showed partial responses (PR), and 22 (44%) had stable disease (SD).The median survival and time to progression were 7 and 2 mo, respectively. After 2 cycles of HAIC, CR was achieved in 1 patient (2%), PR in 10 patients (20%) and SD in 26 patients (52%). Significant pre-treatment prognostic factors were a tumor volume of < 400 cm 3 (P = 0.01) and normal levels of protein induced by vitamin K absence or antagonist (PIVKA)-Ⅱ (P = 0.022). After 2 cycles of treatment, disease control (CR + PR + SD) (P = 0.001), PVTT response (P = 0.003) and α-fetoprotein reduction of over 50% (P = 0.02) were independent factors for survival. Objective response (CR + PR), disease control, PVTT response, and combination therapy during the HAIC were also significant prognostic factors. Adverse events were tolerable and successfully managed. CONCLUSION: HAIC may be an effective treatment modality for advanced HCC with PVTT in patients with tumors < 400 cm 3 and good prognostic factors. | Do Seon Song Si Hyun Bae Myeong Jun Song Sung Won Lee Hee Yeon Kim Young Joon Lee Jung Suk Oh Ho Jong Chun Hae Giu Lee Jong Young Choi Seung Kew Yoon | 2013 | World Journal of Gastroenterology2013，19，29： | 5 |
| 3 | Introduction and constitutive expression of rice chitinase gene in bread wheat using biolistic bombardment and the bar gene as a selectable maker显示文摘 | Chen W P Gu X Liang G H Muthukrishnan S Chen P D Liu D J Giu B S | 1998 | Theor Appl Genet1998，97，12： | 2 |
| 4 | Impact of government spending on employment and output at the state level: 1980-2000 显示文摘 | Gius Mark | 2006 | Journal of Business & Economic Studies2006，12，2： | 1 |
| 5 | Retoperitiona Iaparoseopic nephrectomy 显示文摘 | Giu IS | 1998 | Urol Clin North Am1998，25，2： | 1 |
| 6 | Morphology and phase diagram of complex block copolymers: ABC linear triblock copolymers显示文摘 | Tang Ping Giu Feng Zhang Hongdong | 2004 | Phys Rev E2004，69，： | 1 |
| 7 | High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxi- some proliferator activated receptor alpha selective agonists 显示文摘 | Wang P R Giu Q Ippolito M | 2001 | Eur J Pharmaco12001，427，3： | 1 |
| 8 | Will targeting insulin growth factor help us or hurt us?: An oncologist’s perspective显示文摘 | Mitchell Kamrava David Gius Giovanna Casagrande Elise Kohn | 2009 | Ageing Research Reviews2009，，： | 1 |
| 9 | An orally active selenium based antihypertensive agent with restricted CNS perme ability 显示文摘 | MAY S W WANG L Q GIU W | 1997 | J Pharmacol Exp Ther1997，283，2： | 1 |
| 10 | Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent:mechanism of cell death显示文摘 | Aft RL Zhang FW Gius D | | 0，，07： | 1 |
| 11 | Multiaxial fatigue life prediction method based on path-dependent cycle counting under tension/torsion random loading 显示文摘 | Chen H Shang D G giu E T | 2011 | Fatigue & Fracture of Engineering Materials & Struc-tures2011，34，10： | 1 |
| 12 | Primary angioplasty is superior to intravenous thrombolysis in all subgroup of patients:Results of 9906 patients with acute myocardial infarction显示文摘 | Zahn R Schiele R Giu AK | 1999 | Circulation1999，18，： | 1 |
| 13 | Oxidative stress, redox, and the tumor microenvironment 显示文摘 | Cook JA Gius D Mitchell JB | 2004 | Semin Radiat Oncol2004，14，3： | 1 |
| 14 | Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP显示文摘 | Zhang Y giu R Ni M | 2010 | Biol Chem2010，285，20： | 1 |
| 15 | Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA 显示文摘 | Yu W Gius D Onyango P | 2008 | Nature2008，451，7175： | 1 |
| 16 | Epigenetic silencing of tumour suppressor gene p15 by its autisense RNA 显示文摘 | Yu W Gius D Onyango P | 2008 | Nature2008，451，7175： | 1 |
| 17 | Transformation of LPG into aromatic hydrocarbons and hydrogen over zeolite catalysts显示文摘 | GIU SEPPE G RE INALDO M ROBERTO G | 1994 | Catal Rev Sci Eng1994，36，2： | 1 |
| 18 | Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA 显示文摘 | Yu WQ Gius D Onyango P | 2008 | Nature2008，451，7175： | 1 |
| 19 | Introduction and constitutive expression of rice chitinase gene in bread wheat using biolistic bombardment and the bar gene as a selectable maker显示文摘 | Chen W P Gu X Liang G H Muthukrishnan S Chen P D Liu D J Giu B S | 1998 | Theor Appl Genet1998，97，1： | 1 |
| 20 | An overview of real-time PCR: Applications to quantify cytokine gene expression 显示文摘 | Giu lietti A Overbergh L Valckx D | 2001 | Melhods2001，25，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员